- Home
- SLXN vs TRUG Comparison
SLXN vs TRUG Comparison
Compare SLXN & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- TRUG
- Stock Information
- Founded
- SLXN 2008
- TRUG 1983
- Country
- SLXN Israel
- TRUG United States
- Employees
- SLXN N/A
- TRUG N/A
- Industry
- SLXN
- TRUG
- Sector
- SLXN
- TRUG
- Exchange
- SLXN NYSE
- TRUG NYSE
- Market Cap
- SLXN 7.3M
- TRUG 7.0M
- IPO Year
- SLXN N/A
- TRUG N/A
- Fundamental
- Price
- SLXN $0.78
- TRUG $5.11
- Analyst Decision
- SLXN Strong Buy
- TRUG Strong Buy
- Analyst Count
- SLXN 1
- TRUG 1
- Target Price
- SLXN $5.00
- TRUG $100.00
- AVG Volume (30 Days)
- SLXN 708.9K
- TRUG 74.5K
- Earning Date
- SLXN 08-21-2025
- TRUG 08-13-2025
- Dividend Yield
- SLXN N/A
- TRUG N/A
- EPS Growth
- SLXN N/A
- TRUG N/A
- EPS
- SLXN N/A
- TRUG N/A
- Revenue
- SLXN N/A
- TRUG $22,236,072.00
- Revenue This Year
- SLXN N/A
- TRUG $9.66
- Revenue Next Year
- SLXN N/A
- TRUG $48.94
- P/E Ratio
- SLXN N/A
- TRUG N/A
- Revenue Growth
- SLXN N/A
- TRUG 8.40
- 52 Week Low
- SLXN $0.58
- TRUG $5.00
- 52 Week High
- SLXN $41.85
- TRUG $73.50
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- TRUG 29.32
- Support Level
- SLXN N/A
- TRUG $5.05
- Resistance Level
- SLXN N/A
- TRUG $5.67
- Average True Range (ATR)
- SLXN 0.00
- TRUG 0.52
- MACD
- SLXN 0.00
- TRUG 0.08
- Stochastic Oscillator
- SLXN 0.00
- TRUG 6.43
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.